This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations in Hepatitis C Treatment by Sameh H Soror
Introduction: Sameh H Soror is an accomplished inventor based in Cairo Governorate, Egypt. He has made significant contributions to the field of medical research, particularly in the treatment of chronic hepatitis C, a global health issue affecting millions of individuals.
Latest Patents: One of his notable patents is titled "2-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C virus NS3 protease." This invention introduces new compounds belonging to the class of 2-substituted-1H-imidazole-4-carboxamide derivatives. These compounds are designed to interfere with the essential viral peptide NS4A co-enzyme function, thereby providing a potential therapeutic approach for hepatitis C treatment. The patent includes details on chemical synthesis, spectral confirmation, and binding assays with the NS3 protein.
Career Highlights: Sameh H Soror is affiliated with King Abdulaziz University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on public health, particularly in combating hepatitis C.
Collaborations: Throughout his career, Sameh has collaborated with notable colleagues, including Mohammed A Baradwan and Abdelsattar Mansour Omar. These partnerships have contributed to the advancement of his research and the development of effective treatment options.
Conclusion: Sameh H Soror's contributions to the field of hepatitis C treatment through his innovative patent demonstrate his commitment to addressing significant health challenges. His work exemplifies the importance of research and collaboration in the pursuit of medical advancements.